SYSCHEM (INDIA) LTD. Share Price

SYSCHEM (INDIA) LTD. Share Price

BSE: 531173
|
Pharmaceuticals
|
S Cap
₹ 30.42
-₹0.26 (-0.85%)
1D
Last updated 03 Sep, 2026, 09:36 IST

SYSCHEM (INDIA) LTD. Share Price Today

As of 3 Sep 2026, SYSCHEM (INDIA) LTD. share price is ₹30.42. The stock opened at ₹30.36, compared to its previous close of ₹30.68. During today's trading session, SYSCHEM (INDIA) LTD. share price moved in the range of ₹30.36 to ₹30.51, with an average price of ₹30.44 for the day. Looking at its last 52-week, the stock has touched a low of ₹29.29 and a high of ₹61.49.

₹30.36
0.85% down today
₹30.51
1D LOW
1D HIGH

SYSCHEM (INDIA) LTD. Returns Calculator

Circuit
L
H
₹24.55
₹36.81
52-week
L
H
₹29.29
₹61.49

About SYSCHEM (INDIA) LTD.

SYSCHEM (INDIA) LTD. Share Price
ISIN
INE121D01036
Sector Market Cap
₹ 164.49 Cr

Syschem (India) Limited is an India-based company, which is engaged in the business of manufacturing of active pharmaceutical ingredient (API) / Intermediates. The Company operates through pharmaceuticals segment. The Company’s API/ Intermediates products include Amoxycillin Trihydrate; Ampicillin Trihydrate; Cloxacillin Sodium; Dicloxacillin Sodium; Flucloxacillin Sodium for export only; Cephalexin; Cefixime; Cefadroxil; Distillation of Specialty Solvents, such as dimethylformamide (DMF), acetonitrile, ethyl acetate and tetrahydrofuran (THF). It also engaged in the manufacturing of bulk drugs/ intermediates / specialty chemicals and contract manufacturing. The Company has its manufacturing facility at Village Bargodam, Tehsil Kalka, Distt. Panchkula Haryana.

SYSCHEM (INDIA) LTD. Financial Highlights

  • Revenue: SYSCHEM (INDIA) LTD. reported revenue of ₹573.79 crore in FY26 vs ₹331.72 crore in FY25. It showed an increase of 72.97% on a yearly basis.
  • Operating Profit: SYSCHEM (INDIA) LTD. reported an operating profit of ₹14.79 crore in FY26 vs ₹1.01 crore in FY25. It showed an increase of 1,364.36% on a year-on-year basis.
  • Net Profit: SYSCHEM (INDIA) LTD. reported a net profit of ₹10.93 crore in FY26 vs ₹0.46 crore in FY25. It showed an increase of 2,276.09% on a yearly basis.

SYSCHEM (INDIA) LTD. Quarterly Result Highlights

  • SYSCHEM (INDIA) LTD. reported revenue of ₹109.26 crore in Jun 2026, compared with ₹219.35 crore in Mar 2026, representing a decrease of 50.19% on a quarter-on-quarter (QoQ) basis.
  • SYSCHEM (INDIA) LTD. reported an operating loss of ₹1.45 crore in Jun 2026, compared with ₹5.60 crore in Mar 2026, representing a decrease of 125.89% on a quarter-on-quarter (QoQ) basis.
  • SYSCHEM (INDIA) LTD. reported a loss of ₹1.67 crore in Jun 2026, compared with ₹1.74 crore in Mar 2026, reflecting a decrease of 195.98% on a QoQ basis.
  • The earnings per share (EPS) of SYSCHEM (INDIA) LTD. stood at ₹0.12 during Jun 2026.
Know more
Promoters
63.38%
FII
0.00%
Other DII
0.15%
Retail and other
36.47%
Mutual funds
0.00%
Foreign institutions - FII
FII shareholding by period
Dec 20250.00%
Mar 20260.00%
Jun 20260.00%
Jul 20260.00%
Mkt Cap Cr
164.49
P/E
26.68
P/B
1.14
ROE
8.93%
D/E
0.00
ROCE
13.60%
Div. Yield
0.00%
EPS(TTM)
2.50
Turnover
2.24
EV/EBITDA
8.21
Net Margin
0.00%
Op. Margin
0.00%
ROA
2.10%
Quick Ratio
0.00
Curr. Ratio
1.34
Based on fundamentals, this stock's
Step 1 of 5
Performance
Very Poor
Syschem (India) has not beaten FD return of 7%
Step 1 of 5
Valuation
Overvalued
Syschem (India) appears overvalued compared to its peers
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,63,180.0038.285.5513.74%0.6117.33%93.240.83%0.4810.90
Divis Laboratories2,43,302.0083.7914.6215.32%0.0019.56%629.490.32%0.5598.19
Torrent Pharmaceuticals1,88,623.0088.2922.6425.49%1.6913.85%222.760.68%0.4958.70
Zydus Lifesciences1,16,114.0025.004.2418.59%0.3117.35%237.300.09%0.3335.38
Cipla1,14,554.0034.023.3211.27%0.0014.95%423.360.92%0.4543.52
Laurus Labs1,00,660.0092.3218.9916.77%0.4016.14%97.200.11%0.6713.72
Lupin98,312.2017.734.3823.76%0.0424.88%659.000.84%0.57129.18
Dr. Reddy's Laboratories96,906.3030.442.5511.07%0.1812.54%377.950.69%0.4138.68
Mankind Pharma97,467.0047.546.0311.74%0.3413.13%397.020.04%0.4449.37
Aurobindo Pharma96,836.1025.682.529.25%0.1911.76%394.820.24%0.3841.58

SYSCHEM (INDIA) LTD. Financials

Full statement

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹386.23₹233.48₹130.38₹65.63
Other Income₹0.04₹0.17₹0.25₹0.13
Total Revenue₹386.27₹233.65₹130.63₹65.76
Total Expenses₹385.26₹229.53₹124.47₹67.93
Profit Before Tax₹1.01₹4.11₹6.15-₹2.17
Tax₹0.55₹1.35₹1.64-₹0.47
Profit After Tax₹0.46₹2.76₹4.51-₹1.71
EPS - Basic₹0.12₹0.78₹1.53-₹0.76
EPS - Diluted₹0.11₹0.78₹1.42-₹0.76

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax₹1.01₹4.11₹6.15-₹2.17
Income before WC changes₹4.02₹7.04₹8.97₹0.62
Change in Assets-₹32.46-₹68.00-₹33.37₹17.17
Change in Liabilities₹18.90₹36.66₹17.54-₹17.18
Change in WC-₹13.56-₹31.34-₹15.82-₹0.01
Cash flow from Operations-₹10.09-₹25.65-₹8.49₹1.07
Cash flow from Investing-₹21.67-₹6.46-₹1.65-₹0.78
Cash flow from Financing₹33.81₹31.64₹10.69-₹0.28
Total Cash Flow₹2.04-₹0.48₹0.54₹0.00
Cash (Start of the year)₹0.10₹0.57₹0.03₹0.02
Cash (End of the year)₹2.14₹0.10₹0.57₹0.03

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹55.83₹37.68₹34.15₹36.26
Current Assets₹161.43₹126.35₹58.57₹23.55
Total Assets₹217.26₹164.03₹92.71₹59.81
Current Liabilities₹124.05₹96.77₹42.98₹25.54
Net Current Asset₹37.38₹29.58₹15.59-₹2.00
Non-Current Liabilities₹1.92₹10.30₹27.43₹27.33
Equity Capital₹91.29₹56.96₹22.30₹6.94
Total Equity & Liabilities₹217.26₹164.03₹92.71₹59.81
* All values are in INR Crore
Qty
Bid
478
30.45
350
30.42
200
30.4
10
30.38
25
30.37
Ask
Qty
30.97
13
30.98
150
30.99
200
31
450
31.2
100
Bid Total: 1063
Ask Total: 913
Buy orders: 54%
Sell orders: 46%
Bearish
2
Neutral
6
Bullish
0
Slightly Bearish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
32.62
Neutral
ATR (14)
1.32
Neutral
STOCH(9,6)
32.02
Neutral
STOCH RSI (14)
68.61
Neutral
ADX(9)
32.07
Bearish
UO(9)
50.77
Neutral
ROC(12)
-2.76
Bearish
WillR(14)
-55.31
Neutral
Period
Simple value
Exponential vaue
5D
31.14
31.06
10D
31.24
31.34
20D
31.39
32.59
50D
37.6
36.64
100D
43.14
40.53
Volume trend — traded volume by day
3 Sep0L
2 Sep0L
1 Sep0L
31 Aug0L
28 Aug0L
27 Aug0L
Average0L
Compare against other stocks
SYSCHEM (INDIA) LTD. Share Price
SYSCHEM (INDIA) LTD.
Pharmaceuticals
Add Stock
Add Another

SYSCHEM (INDIA) LTD. Share Price FAQs